Drug Type Small molecule drug |
Synonyms Cerebrate, Pinitol, NIC 515 + [2] |
Target |
Action inhibitors |
Mechanism APP inhibitors(Beta amyloid A4 protein inhibitors), γ-secretase inhibitors(Gamma-secretase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC7H14O6 |
InChIKeyDSCFFEYYQKSRSV-KLJZZCKASA-N |
CAS Registry10284-63-6 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Alzheimer Disease | Phase 2 | United States | 01 Jan 2007 | |
| Renal fibrosis | Preclinical | South Korea | 15 Nov 2016 |
Phase 2 | 15 | (NIC5-15) | crgjhgvyhr = ttegzolhqy adaehdiyhc (gabnzmxaws, yhpsmzmxof - xaaeyomxcw) View more | - | 09 Jan 2017 | ||
Placebo (Placebo) | crgjhgvyhr = qhsvipanyu adaehdiyhc (gabnzmxaws, xodcovolqt - hhdowangcu) View more |





